Bernard Desablens Selected Research

Bernard Desablens Research Topics

8	Hodgkin Disease (Hodgkin's Disease) 01/2013 - 01/2000
3	Neoplasms (Cancer) 01/2009 - 05/2005
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2009 - 05/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2005 - 06/2005
1	Lymphoma (Lymphomas) 09/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2009
1	GATA2 Deficiency 01/2009
1	Hematologic Neoplasms (Hematological Malignancy) 01/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2005
1	Septic Shock (Toxic Shock Syndrome) 12/2002
1	Mediastinal Diseases 11/2002
1	Neurosarcoidosis 01/2000

8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 11/2002
6	Dacarbazine (DIC)FDA LinkGeneric 01/2013 - 11/2002
6	Vinblastine (Vinblastine Sulfate)FDA Link 01/2013 - 11/2002
6	Bleomycin (Blenoxane)FDA LinkGeneric 01/2013 - 11/2002
2	AnthracyclinesIBA 02/2008 - 11/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2005 - 11/2002
2	Methylprednisolone FDA LinkGeneric 01/2004 - 11/2002
2	Methotrexate (Mexate)FDA LinkGeneric 01/2004 - 11/2002
2	Epirubicin (Ellence)FDA LinkGeneric 01/2004 - 11/2002
1	epoetin betaIBA 01/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2005
1	Prednisone (Sone)FDA LinkGeneric 05/2005
1	Teniposide (VM 26)FDA Link 05/2005
1	InterferonsIBA 05/2005
1	Alkylating AgentsIBA 01/2004
1	Vincristine (Oncovin)FDA LinkGeneric 11/2002
1	Etoposide (VP 16)FDA LinkGeneric 11/2002